Moderna to slash costs by $1.1B - LinkedIn

Sep 12, 2024 · Moderna plans to cut costs by $1.1 billion by 2027 as the biotech company realigns its business amid waning demand for its COVID-19 vaccine.

$1
OFF

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024 · Moderna plans to cut costs by $1.1 billion by 2027 as the biotech company realigns its business amid waning demand for its COVID-19 vaccine.

linkedin.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024 · Moderna aims to generate the savings through portfolio reprioritizations and cost efficiencies. Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 …

fiercebiotech.com

$1
OFF

Moderna Surprises The Street By Predicting A Bigger-than …

2 weeks from now

2 days ago · The company also said it was speeding up and expanding a cost-cutting plan. It expects to cut cash costs by $1 billion in the new year, with additional cuts planned in 2026. …

apnews.com

$1
OFF

Moderna Cuts R&D Budget By $1.1B | Luke Horrigan Posted On

2 weeks from now

Moderna's recent decision to reduce its R&D budget by $1.1 billion reflects a significant strategic adjustment amid declining COVID-19 revenues. The company is…

linkedin.com

20%
OFF

Fierce Biotech On LinkedIn: Moderna Targets $1.1B In R&D …

2 weeks from now

Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to shrink the budget by more than 20% follows commercial setbacks that have persuaded the biotech to take a “more ...

linkedin.com

$1
OFF

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024 · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

24%
OFF

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

2 weeks from now

2 days ago · Shares plunge more than 24% in early trading 2025 revenue forecast misses expectations, prior view CEO Bancel says to reduce 2025 cash costs by $1 bln Jan 13 …

reuters.com

$1
OFF

Moderna's Strategic Pivot To Boost Growth | Brian Pia Posted

2 weeks from now

Moderna's Strategic Pivot Moderna has announced plans to reduce expenses by $1.1 billion by 2027 and focus on securing approvals for 10 new products. The…

linkedin.com

$1
OFF

Moderna Surprises The Street By Predicting A Bigger-than …

2 weeks from now

2 days ago · Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. ... It expects to cut cash costs by $1 billion in the new year ...

go.com

$1
OFF

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

4 days ago · Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a massive $1.1 billion a year from 2027, reversing years of …

pharmaphorum.com

$1
OFF

Moderna To Cut R&D Expenses By $1.1B | Pharma Manufacturing

2 weeks from now

Sep 12, 2024 · This week, Moderna outlined its R&D progress and cost-cutting strategy, aiming for 10 product approvals by 2027 while reducing expenses. To streamline operations, …

pharmamanufacturing.com

20%
OFF

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024 · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Sep 12, 2024 · Moderna projects fiscal 2025 revenue of between $2.5 billion to $3.5 billion compared to analyst projections of $2.9 billion, and said Thursday that it expects to break even …

investopedia.com

$1
OFF

Andrew Richland, MBA, CSCP, CPIM On LinkedIn: Moderna Shares …

2 weeks from now

Moderna shares fell Thursday morning as the COVID vaccine maker said it plans to cut R&D spending by $1.1 billion over the next three years. Moderna Stock Drops on Plans To Cut …

linkedin.com

$1
OFF

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024 · Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the …

kiplinger.com

$1
OFF

Moderna Cuts Sales Forecast On Weaker Vaccine Demand - Yahoo …

2 weeks from now

2 days ago · Moderna cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine. The company now expects …

yahoo.com

$1
OFF

Moderna Posts Surprise Profit As Covid Vaccine Sales Impress, Cost …

2 weeks from now

Nov 7, 2024 · Shares of Moderna were flat Thursday. Moderna is slashing expenses, with a recently announced goal of achieving $1.1 billion in savings by 2027, as it tries to recover from the rapid decline of ...

nbcnewyork.com

21%
OFF

Why Moderna Stock Just Crashed 21% | The Motley Fool

2 weeks from now

2 days ago · CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 …

fool.com

$1
OFF

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

2 days ago · (Reuters) -Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its ...

yahoo.com

25%
OFF

Moderna: Plans To Cut Costs By E1bn By 2025 - MarketScreener

2 weeks from now

2 days ago · In 2024, we achieved product sales of between $3 and $3.1 billion, reduced our operating costs by more than 25% compared with 2023, and aim to reduce them by $1 billion …

marketscreener.com

20%
OFF

Moderna Slashes 2025 Forecast, Stock Sinks 20%

2 weeks from now

Jan 8, 2025 · Moderna has lowered its 2025 revenue outlook from an estimated $2.5–$3.5 billion to just $1.5–$2.5 billion, citing hurdles like increased Covid competition and dwindling …

brandvm.com

FAQs about Moderna to slash costs by $1.1B - LinkedIn Coupon?

How much did Moderna make in 2024?

The company generated product sales of between $3 billion and $3.1 billion in 2024. That total is less than half of the $6.67 billion in net product sales reported in 2023, and is on the low end of Moderna's previous guidance range. But investors were even more disappointed by Moderna's outlook for 2025. ...

How much will Moderna spend on R&D by 2027?

Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the company will shift its focus to winning approvals for the 10 products in its pipeline. ...

Will Moderna be approved by 2027?

Moderna also has five nonrespiratory products across cancer, latent viruses and rare diseases that could be approved by 2027, according to the company’s release. The company expects 2025 revenue to come in at $2.5 billion to $3.5 billion. From 2026 to 2028, Moderna expects a compounded annual growth rate of more than 25% as new products launch. ...

Where is Moderna headquartered?

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid business. The biotech company said it expects 10 new product approvals through 2027. ...

Will Moderna lose money in 4 years?

Analysts think Moderna will lose money for at least four years. Moderna 's (MRNA -20.49%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Why is Moderna stock plunging?

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. ...